Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
434 studies found for:    Open Studies | "Urinary Bladder Diseases"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Urinary Bladder Diseases"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting A Phase 2 Study of B-701 in Treatment of Locally Advanced or Metastatic Urothelial Cell Carcinoma
Conditions: Locally Advanced or Metastatic Urothelial Cell Carcinoma;   Urinary Bladder Disease;   Urological Diseases
Interventions: Drug: B-701;   Drug: Docetaxel;   Drug: placebo
2 Recruiting A Prospective, Observational, Multicenter Study of Patients Following Initiation of a New Course of Treatment for Overactive Bladder (OAB)
Conditions: Urinary Bladder Overactive;   Overactive Bladder;   Urinary Bladder Diseases;   Urologic Diseases
Interventions: Drug: mirabegron;   Drug: antimuscarinic medication
3 Recruiting 3D HD Versus 2D HD in Cholecystectomy
Conditions: Cholelithiasis;   Gall Bladder Disease
Interventions: Device: 3D HD laparoscopy;   Device: 2D HD laparoscopy
4 Unknown  Prospective Multicenter Human Randomized Controlled Evaluation of NOTES® Cholecystectomy
Condition: Gall Bladder Diseases
Interventions: Procedure: NOTES Cholecystectomy;   Procedure: Laparoscopic Cholecystectomy
5 Recruiting Vicinium Treatment for Subjects With Non-muscle Invasive Bladder Cancer Previously Treated With BCG
Condition: Bladder Cancer
Intervention: Biological: Vicinium
6 Unknown  Biomechanical Assessment of Level Gait in Patient's Status Post Bladder Exstrophy
Condition: Bladder Exstrophy
Intervention:
7 Recruiting Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer
Conditions: Bladder Cancer;   Carcinoma, Transitional Cell;   Renal Pelvis Cancer;   Ureter Cancer;   Urethra Cancer
Interventions: Drug: Enzalutamide;   Drug: Cisplatin;   Drug: Gemcitabine
8 Not yet recruiting Phase 2 Durvalumab (Medi4736) for Bacillus Calmette-Guérin (BCG) Refactory Urothelial Carcinoma in Situ of the Bladder
Conditions: Carcinoma in Situ of Bladder;   Bladder Cancer
Interventions: Drug: Durvalumab;   Procedure: Cystoscopy with Biopsy
9 Not yet recruiting Mirabegron For Erectile Dysfunction
Conditions: Erectile Dysfunction;   Overactive Bladder;   Urinary Incontinence
Intervention: Drug: Mirabegron
10 Recruiting A Study to Determine if Mesh Placement During Bladder Surgery Can Reduce the Chances of Developing a Hernia
Condition: Bladder Cancer
Interventions: Procedure: Surgery Radical Cystectomy;   Procedure: Ultrapro mesh
11 Not yet recruiting MED-C Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice
Conditions: Neoplasms;   Lung Neoplasms;   Colon Neoplasms;   Breast Neoplasms;   Pancreatic Neoplasms;   Prostate Neoplasms;   Kidney Neoplasms;   Liver Neoplasms;   Rectal Neoplasms;   Hematologic Neoplasms;   Multiple Myeloma;   Myelodysplastic Syndromes;   Ovarian Neoplasms;   Bladder Neoplasms;   Testicular Neoplasms;   Endometrial Neoplasms;   Brain Neoplasms;   Biliary Tract Neoplasms;   Head and Neck Neoplasms;   Uterine Cervical Neoplasms;   Skin Neoplasms;   Melanoma;   Gastric Neoplasms;   Anal Neoplasms;   Sarcoma
Intervention: Other: Provider determined
12 Recruiting Trans-MAPP II Study of Urologic Chronic Pelvin Pain
Conditions: Interstitial Cystitis;   Chronic Prostatitis
Intervention:
13 Not yet recruiting A Personalized Cancer Vaccine (NEO-PV-01) w/ Nivolumab for Patients With Melanoma, Lung Cancer or Bladder Cancer
Conditions: Urinary Bladder Cancer;   Bladder Tumors;   Transitional Cell Carcinoma of the Bladder;   Malignant Melanoma;   Melanoma;   Skin Cancer;   Carcinoma, Non-Small-Cell Lung;   Lung Cancer
Interventions: Biological: NEO-PV-01;   Biological: Nivolumab;   Other: Adjuvant
14 Not yet recruiting Palbociclib With Cisplatin or Carboplatin in Advanced Solid Tumors
Conditions: Solid Neoplasm;   Stage III Pancreatic Cancer;   Stage IIIA Breast Cancer;   Stage IIIA Non-Small Cell Lung Cancer;   Stage IIIB Breast Cancer;   Stage IIIB Non-Small Cell Lung Cancer;   Stage IIIC Breast Cancer;   Stage IV Breast Cancer;   Stage IV Non-Small Cell Lung Cancer;   Stage IVA Pancreatic Cancer;   Stage IVB Pancreatic Cancer;   Sarcoma;   Colorectal Cancer;   Head and Neck Cancer;   Cancer of Unknown Primary;   Bladder Cancer;   Ovarian Cancer
Interventions: Drug: Carboplatin;   Drug: Cisplatin;   Drug: Palbociclib
15 Recruiting Effect on Xpert® Bladder Test of Urines Inflammatory Milieu Induced by BCG Treatment of Patients With NMIBC
Conditions: Non Muscle Invasive Bladder Cancer;   Treatment by BCG
Intervention: Biological: Xpert bladder Test
16 Not yet recruiting A Randomized Controlled Trial of Permanent vs Absorbable Suture for Uterosacral Ligament Suspension
Conditions: Pelvic Organ Prolapse;   Cystocele;   Uterine Prolapse
Intervention: Device: Absorbent suture (polydioxanone) and Permanent suture (Gore-Tex CV2)
17 Not yet recruiting Nab-paclitaxel Plus Gemcitabine as First-line Therapy for Cisplatin-ineligible or Cisplatin-incurable Advanced Urothelial Carcinoma
Conditions: Urothelial Carcinoma;   Bladder Cancer;   Transitional Cell Carcinoma
Interventions: Drug: nab-paclitaxel;   Drug: Gemcitabine
18 Recruiting A Study of Combinations of D-CIK Immunotherapy And Anti-PD-1 In Refractory Solid Tumors
Conditions: Hepatocellular Carcinoma;   Renal Cell Carcinoma;   Bladder Cancer;   Colorectal Cancer;   Non-small-cell Lung Cancer;   Breast Cancer
Intervention: Biological: D-CIK and anti-PD-1 antibody
19 Recruiting Outpatient PDD Guided Laser Mediated Destruction of Bladder Tumors
Condition: Bladder Cancer
Interventions: Device: Bladder tumor resection using diathermia;   Device: Diode laser (980 nm) tumor destruction
20 Not yet recruiting Celecoxib With Chemotherapy in Localized, Muscle-Invasive Bladder Cancer
Condition: Bladder Cancer
Interventions: Drug: Celecoxib;   Drug: Gemcitabine;   Drug: Cisplatin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years